Alnylam Pharmaceuticals Inc A1LN34 Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Brazil
BOV
Alnylam Pharmaceuticals Inc (A1LN34)
Alnylam Pharmaceuticals Inc (A1LN34) Financials

Alnylam Pharmaceuticals Inc (A1LN34)

73.85

0.35

(0.48%)

Closed 26 December 7:55AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-30.959	-30.138	-42.666	-44.641	-29.585	-24.192	-31.466	-11.937
Return on Equity (%)	-37.54	-36.542	-49.635	-64.664	-69.923	-106.307	-526.144	232.399
Return on Invested Capital (%)	-52.899	-42.702	-53.884	-70.058	-65.765	-61.157	-82.171	-40.288
Operating Margin (%)	-869.628	-545.949	-1015.478	-402.846	-156.457	-83.991	-93.6	-17.081
Net Profit Margin (%)	-869.628	-545.949	-1016.576	-403.238	-174.145	-101.011	-109.036	-24.079
Book Value Per Share	10.708	17.723	12.868	12.824	8.729	4.894	-1.277	-1.758
Earnings Per Share	-4.772	-4.925	-7.526	-7.898	-7.372	-7.096	-9.128	-3.508
Cash Per Share	2.253	6.475	4.153	4.877	4.265	6.823	6.991	6.476
Working Capital Per Share	6.285	16.259	10.093	12.152	17.432	17.581	15.528	16.056
Operating Profit Per Share	0.549	0.902	0.723	1.735	3.563	6.255	7.368	12.526
EBIT Per Share	-4.772	-4.925	-7.518	-7.891	-7.349	-7.09	-9.094	-3.455
EBITDA Per Share	-4.772	-4.925	-7.518	-7.891	-7.349	-7.09	-9.094	-3.455
Free Cash Flow Per Share	-4.132	-3.999	-6.399	-6.797	-7.027	-6.856	-8.905	-3.443

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	85.94M	99.67M	101.18M	112.19M	116.43M	120.18M	123.93M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	123.93M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-44.914	N/A	N/A	N/A	-5.732	N/A	N/A
Net Profit Margin (%)	N/A	-54.528	N/A	N/A	N/A	-13.338	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	9.22B
Price to Earnings Ratio	-69.34
Price to Sales Ratio	16.7
Price to Cash Ratio	37.56
Price to Book Ratio	-138.35
Dividend Yield	-

Share Statistics

Shares Outstanding	125.49M
Average Volume (1 week)	183
Average Volume (1 Month)	242
52 Week Change	54.11%
52 Week High	85.44
52 Week Low	36.23

More Ratios Coming Soon!

Alnylam Pharmaceuticals

Eight Solutions

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions